{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:39:23Z","timestamp":1792024763640,"version":"4.4.0"},"reference-count":28,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Applied Research Collaboration East Midlands"},{"name":"ARC"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Traditional diabetes self-monitoring of blood glucose (SMBG) involves inconvenient finger pricks. Continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems offer CGM, enhancing type 2 diabetes (T2D) management with convenient, comprehensive data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PURPOSE<\/jats:title>\n                  <jats:p>To assess the benefits and potential harms of CGM and isCGM compared with usual care or SMBG in individuals with T2D.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DATA SOURCES<\/jats:title>\n                  <jats:p>We conducted a comprehensive search of MEDLINE, Embase, the Cochrane Library, Web of Science, and bibliographies up to August 2023.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY SELECTION<\/jats:title>\n                  <jats:p>We analyzed studies meeting these criteria: randomized controlled trials (RCT) with comparison of at least two interventions for \u22658 weeks in T2D patients, including CGM in real-time\/retrospective mode, short-\/long-term CGM, isCGM, and SMBG, reporting glycemic and relevant data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DATA EXTRACTION<\/jats:title>\n                  <jats:p>We used a standardized data collection form, extracting details including author, year, study design, baseline characteristics, intervention, and outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DATA SYNTHESIS<\/jats:title>\n                  <jats:p>We included 26 RCTs (17 CGM and 9 isCGM) involving 2,783 patients with T2D (CGM 632 vs. usual care\/SMBG 514 and isCGM 871 vs. usual care\/SMBG 766). CGM reduced HbA1c (mean difference \u22120.19% [95% CI \u22120.34, \u22120.04]) and glycemic medication effect score (\u22120.67 [\u22121.20 to \u22120.13]), reduced user satisfaction (\u22120.54 [\u22120.98, \u22120.11]), and increased the risk of adverse events (relative risk [RR] 1.22 [95% CI 1.01, 1.47]). isCGM reduced HbA1c by \u22120.31% (\u22120.46, \u22120.17), increased user satisfaction (0.44 [0.29, 0.59]), improved CGM metrics, and increased the risk of adverse events (RR 1.30 [0.05, 1.62]). Neither CGM nor isCGM had a significant impact on body composition, blood pressure, or lipid levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS<\/jats:title>\n                  <jats:p>Limitations include small samples, single-study outcomes, population variations, and uncertainty for younger adults. Additionally, inclusion of &amp;lt;10 studies for most end points restricted comprehensive analysis, and technological advancements over time need to be considered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Both CGM and isCGM demonstrated a reduction in HbA1c levels in individuals with T2D, and unlike CGM, isCGM use was associated with improved user satisfaction. The impact of these devices on body composition, blood pressure, and lipid levels remains unclear, while both CGM and isCGM use were associated with increased risk of adverse events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc23-1520","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T20:06:02Z","timestamp":1703102762000},"page":"169-179","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":120,"title":["Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence"],"prefix":"10.2337","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-7018","authenticated-orcid":false,"given":"Samuel","family":"Seidu","sequence":"first","affiliation":[{"name":"1Diabetes Research Centre, National Institute for Health Research, Applied Research Collaboration East Midlands, University of Leicester, Leicester, U.K."},{"name":"2Diabetes Research Centre, University of Leicester, National Institute for Health Research Biomedical Research Centre, Leicester General Hospital, Leicester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setor K.","family":"Kunutsor","sequence":"additional","affiliation":[{"name":"1Diabetes Research Centre, National Institute for Health Research, Applied Research Collaboration East Midlands, University of Leicester, Leicester, U.K."},{"name":"2Diabetes Research Centre, University of Leicester, National Institute for Health Research Biomedical Research Centre, Leicester General Hospital, Leicester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi A.","family":"Ajjan","sequence":"additional","affiliation":[{"name":"3Clinical Population and Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[{"name":"1Diabetes Research Centre, National Institute for Health Research, Applied Research Collaboration East Midlands, University of Leicester, Leicester, U.K."},{"name":"2Diabetes Research Centre, University of Leicester, National Institute for Health Research Biomedical Research Centre, Leicester General Hospital, Leicester, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"2023122020052843900_B1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"2023122020052843900_B2","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"key":"2023122020052843900_B3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/193229681300700225","article-title":"Self-monitoring of blood glucose in type 2 diabetes: recent studies","volume":"7","author":"Schnell","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"2023122020052843900_B4","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/diacare.24.11.1858","article-title":"Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes","volume":"24","author":"Boland","year":"2001","journal-title":"Diabetes Care"},{"key":"2023122020052843900_B5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/diacare.26.4.1153","article-title":"The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control","volume":"26","author":"Chico","year":"2003","journal-title":"Diabetes Care"},{"key":"2023122020052843900_B6","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc18-1150","article-title":"Clinical implications of real-time and intermittently scanned continuous glucose monitoring","volume":"41","author":"Edelman","year":"2018","journal-title":"Diabetes Care"},{"key":"2023122020052843900_B7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2337\/dc10-1989","article-title":"Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes","volume":"34","author":"Battelino","year":"2011","journal-title":"Diabetes Care"},{"key":"2023122020052843900_B8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4158\/EP161392.CS","article-title":"Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology","volume":"22","author":"Fonseca","year":"2016","journal-title":"Endocr Pract"},{"key":"2023122020052843900_B9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/193229681100500419","article-title":"Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials","volume":"5","author":"Gandhi","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"2023122020052843900_B10","doi-asserted-by":"crossref","first-page":"d3805","DOI":"10.1136\/bmj.d3805","article-title":"Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data","volume":"343","author":"Pickup","year":"2011","journal-title":"BMJ"},{"key":"2023122020052843900_B11","doi-asserted-by":"crossref","first-page":"4684815","DOI":"10.1155\/2019\/4684815","article-title":"Utility of real-time and retrospective continuous glucose monitoring in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"2019","author":"Ida","year":"2019","journal-title":"J Diabetes Res"},{"key":"2023122020052843900_B12","first-page":"CD008101","article-title":"Continuous glucose monitoring systems for type 1 diabetes mellitus","volume":"1","author":"Langendam","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2023122020052843900_B13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1758-5996-5-39","article-title":"Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes","volume":"5","author":"Poolsup","year":"2013","journal-title":"Diabetol Metab Syndr"},{"key":"2023122020052843900_B14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2023122020052843900_B15","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","article-title":"Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis","volume":"4","author":"Kunutsor","year":"2017","journal-title":"Lancet Haematol"},{"key":"2023122020052843900_B16","doi-asserted-by":"crossref","first-page":"e00303","DOI":"10.1002\/edm2.303","article-title":"Benefits and harms of sodium-glucose co-transporter-2 inhibitors (SGLT2-I) and renin-angiotensin-aldosterone system inhibitors (RAAS-I) versus SGLT2-Is alone in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Seidu","year":"2022","journal-title":"Endocrinol Diabetes Metab"},{"key":"2023122020052843900_B17","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2023122020052843900_B18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2023122020052843900_B19","author":"Goldenberg","year":"2021"},{"key":"2023122020052843900_B20","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3390\/nu14204391","article-title":"Comparison of the effectiveness of low carbohydrate versus low fat diets, in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Apekey","year":"2022","journal-title":"Nutrients"},{"key":"2023122020052843900_B21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"2023122020052843900_B22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2023122020052843900_B23","first-page":"e5634","article-title":"Continuous glucose monitoring versus self-monitoring of blood glucose in type 2 diabetes mellitus: a systematic review with meta-analysis","volume":"11","author":"Janapala","year":"2019","journal-title":"Cureus"},{"key":"2023122020052843900_B24","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/dom.13845","article-title":"Impact of technology on glycaemic control in type 2 diabetes: a meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion","volume":"21","author":"Dicembrini","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2023122020052843900_B25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001092","article-title":"Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis","volume":"8","author":"Castellana","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2023122020052843900_B26","doi-asserted-by":"crossref","first-page":"849725","DOI":"10.3389\/fcdhc.2022.849725","article-title":"Efficacy of flash glucose monitoring in type 1 and type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials","volume":"3","author":"Liang","year":"2022","journal-title":"Front Clin Diabetes Healthc"},{"key":"2023122020052843900_B27","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.2337\/dc20-1690","article-title":"Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF study","volume":"44","author":"Roussel","year":"2021","journal-title":"Diabetes Care"},{"key":"2023122020052843900_B28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/19322968211070855","article-title":"The benefits of utilizing continuous glucose monitoring of diabetes mellitus in primary care: a systematic review","volume":"17","author":"Kieu","year":"2023","journal-title":"J Diabetes Sci Technol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/47\/1\/169\/741650\/dc231520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/47\/1\/169\/741650\/dc231520.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T20:06:13Z","timestamp":1703102773000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/47\/1\/169\/154009\/Efficacy-and-Safety-of-Continuous-Glucose"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,20]]},"published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc23-1520","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]}}}